On June 21, under the coordination of Sun Yuewu, Secretary-General of the Chinese Herbal Formula Granules Industry Alliance, Shen Fanshun, Chairman of the company, led a core team comprising production, R&D, procurement, and marketing representatives to Jiangxi Baishen Pharmaceutical Co., Ltd. for an exchange and learning session. The two sides discussed key issues including R&D breakthroughs, process optimization, market expansion, and supply chain development, jointly mapping out a collaborative blueprint.

Accompanied by Ms.Zhang Chaoxia, Executive Vice President of Baishen Pharmaceutical, the Chun Guang Jiu Hui team toured the company's exhibition hall and intelligent Chinese herbal decoction center, gaining a comprehensive understanding of Baishen Pharmaceutical's development history and industrial layout.

At the symposium, Chairman Fu Cheng of Baishen Pharmaceutical extended a warm welcome to Chun Guang Jiu Hui's delegation. He outlined the company's strategic vision for the industry and detailed its plans to strengthen competitiveness in the traditional Chinese medicine formula granules sector by leveraging the full industrial chain. The chairman emphasized that capitalizing on the unique advantages of Hunan-Jiangxi region's authentic medicinal resources holds strategic significance for the industry's development.

Shen Fanshun expressed gratitude for Baishen Pharmaceutical's warm hospitality and fully endorsed Chairman Fu Cheng's visionary strategic planning and open collaboration ethos. He elaborated on the historical evolution and current development status of Chun Guang Jiu Hui, noting that the traditional Chinese medicine formula granules industry is at a pivotal stage of growth. He urged both parties to actively engage in exchanges and cooperation, overcome developmental bottlenecks, and jointly promote the industry's healthy development.

Secretary-General Sun Yuewu highly commended the value of this exchange, describing it as a vivid demonstration of collaborative development among leading enterprises in the industry. By examining the evolution of national healthcare reform policies over the years, tracing the origins of medicinal materials, analyzing the supply chain of raw herbs, exploring process innovations and standardization, and investigating market integration and product value chains, he highlighted both opportunities and challenges for the development of the Chinese herbal formula granules industry.

Subsequently, the teams from both sides divided into groups based on their respective fields to conduct in-depth discussions and share experiences.

This exchange has strengthened the mutual understanding between the two sides, deepened the mutual trust in technology and resources, and laid a foundation for the future comprehensive and deepened cooperation between the two sides.